TauRX Therapeutics TRX-015
Back to Drug Development Trials
Drug Development Trials
About the trial
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer’s Disease with an Open Label Extension.